GlobalGov › United States › Award

BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL won THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA from the Government of United States

the Government of United States · United States government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$122.5M
Award Value
September 30, 2024
Award Date
Awarded
Status

Award Overview

BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL was awarded THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA by the Government of United States in United States, tracked by GlobalGov. The award is valued at $122.5M. It was awarded on September 30, 2024. Classification: NAICS 541714, PSC AN42. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeBASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
Awarding agencythe Government of United States
CountryUnited States
Award value$122.5M
Award dateSeptember 30, 2024
NAICS541714
PSCAN42
Place of performanceUnited States
Last verifiedSeptember 1, 2026

Source: U.S. Government (USAspending.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

United States market overview →Browse open opportunities →

Track every United States contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required